Understanding and overcoming barriers to human papillomavirus vaccine acceptance

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue SUPPL. 1, 2006, Pages

  Zimet, Gregory D ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b Section of Adolescent Medicine   (United States)

Author keywords

Cervical cancer; Genital warts; Human papillomavirus (HPV); Vaccines

Indexed keywords

WART VIRUS VACCINE;

CANCER DIAGNOSIS; COMMUNICATION SKILL; CONDYLOMA; HEALTH CARE COST; HEALTH PRACTITIONER; HUMAN; NONHUMAN; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VACCINATION; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CHILD; FEMALE; HUMANS; MALE; MASS IMMUNIZATION; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENT-CHILD RELATIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; UTERINE CERVICAL NEOPLASMS;

EID: 33746426005     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000216317.10690.8f     Document Type: Review

References (49)

1. Harper DM. Why am I scared of HPV? CA Cancer J Clin 2004; 54:245-247.
2. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004; 96:604-615.
3. Taira AV. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 2004; 10:1915-1923.
4. Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 2003; 290:781-789.
5. Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000; 27:49-52.
6. Mays RM, Zimet GD, Winston Y, et al. Human papillomavirus, genital warts, pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000; 21:361-374.
7. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000; 96:653-656.
8. Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002; 17:706-714.
9. Holcomb B, Bailey JM, Crawford K, Ruffin MT IV, et al. Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract 2004; 17:26-31.
10. Waller J, McCaffery K, Forrest S, et al. Awareness of human papillomavirus among women attending a well woman clinic. Sexually Transm Infect 2003; 79:320-322.
11. Blake DR, Weber BM, Fletcher KE. Adolescent and young adult women's misunderstanding of the term Pap smear. Arch Pediatr Adolesc Med 2004; 158:966-970.
12. Kahn JA, Chiou V, Allen JD, et al. Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Arch Pediatr Adolesc Med 1999; 153:1046-1054.
13. Anhang R, Wright TC Jr, Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 2004; 100:315-320.
14. Zimet GD, Mays RM, Winston Y, et al. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000; 9:47-50.
15. Hoover DR, Carfioli B, Moench EA. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int 2000; 21:375-391.
16. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003; 14:300-306.
17. Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003; 30:774-778.
18. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, et al. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca. Mexico Arch Med Res 2001; 32:243-247.
19. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004; 58:1405-1413.
20. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Lower Gen Tract Dis 2004; 8:188-194.
21. Zimet GD, Mays RM, Sturm LA, et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005; 159:132-137.
22. Rosenthal SL, Kottenhahn RK, Biro FM, Succop PA. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health 1995; 17:248-254.
23. Mays RM, Zimet GD. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis 2004; 31:428-432.
24. Raley JC, Followwill KA, Zimet GD, Ault KA. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004; 12:127-133.
25. Rupp R, Stanberry LR, Rosenthal SL. New biomedical approaches for sexually transmitted infection prevention: vaccines and microbicides. Adolesc Med Clin 2004; 15:393-407.
26. Siegel RM, Baker RC, Kotagal UR, Balistreri WF. Hepatitis B vaccine use in Cincinnati: a community's response to the AAP recommendation of universal hepatitis B immunization. J Natl Med Assoc 1994; 86:444-448.
27. Maheux B, Haley N, Rivard M, Gervais A. STD risk assessment and risk-reduction counseling by recently trained family physicians. Acad Med 1995; 70:726-728.
28. Millstein SG, Igra V, Gans J. Delivery of STD/HIV preventive services to adolescents by primary care physicians. J Adolesc Health 1996; 19:249-257.
29. Schuster MA, Bell RM, Petersen LP, Kanouse DE. Communication between adolescents and physicians about sexual behavior and risk prevention. Arch Pediatr Adolesc Med 1996; 150:906-913.
30. Torkko KC, Gershman K, Crane LA, et al. Testing for Chlamydia and sexual history taking in adolescent females: results from a statewide survey of Colorado primary care providers. Pediatrics 2000; 106:E32.
31. Kahn JA, Emans SJ, Goodman E. Measurement of young women's attitudes about communication with providers regarding Papanicolaou smears. J Adolesc Health 2001; 29:344-351.
32. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls. Arch Pediatr Adolesc Med 2000; 154:127-134.
33. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428.
34. Tarkowski TA, Koumans EH, Sawyer M, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004; 189:46-50.
35. Brown DR, Shew ML, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191:182-192.
36. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132:277-284.
37. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415-1423.
38. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. Can Med Assoc J 2003; 168:421-425.
39. Anhang R, Stryker JE, Wright TC Jr, Goldie SJ. News media coverage of human papillomavirus. Cancer 2004; 100:308-314.
40. Borzekowski DL, Rickert VI. Adolescent cybersurfing for health information: a new resource that crosses barriers. Arch Pediatr Adolesc Med 2001; 155:813-817.
41. Davies P, Chapman S, Leask J. Antivaccination activists on the world wide web. Arch Dis Child 2002; 87:22-25.
42. Leask J, Chapman S. An attempt to swindle nature: press anti-immunisation reportage. Aust NZ J Pub Health 1998; 22:17-26.
43. Lashuay N, Tjoa T, de Nuncio ML, et al. Exposure to immunization media messages among African American parents. Prev Med 2000; 31:522-528.
44. Ball LK, Evans G, Bostrom A. Risky business: challenges in vaccine risk communication. Pediatrics 1998; 101:453-458.
45. Evans G, Bostrom A. The evolution of vaccine risk communication in the United States: 1982-2002. In: Jordan Report 20th Anniversary: accelerated development of vaccines 2002. National Institute of Allergy and Infectious Diseases. Washington, DC: US Department of Health and Human Services, National Institute of Allergy and Infectious Diseases; 2002. pp. 58-71.
46. Sturm LA, Mays RM, Zimet GD. Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr 2005; 26:441-452.
47. Spigener SD, Mayeaux EJ Jr. Patient education and issues of HPV infection. Hosp Pract (Off Ed) 1998; 33:133-135.
48. Anhang R, Goodman A, Goldie SJ. HPV communication: review of existing research and recommendations for patient education. CA Cancer J Clin 2004; 54:248-259.
49. Gilbert LK, Alexander L, Grosshans JF, Jolley L. Answering frequently asked questions about HPV. Sex Transm Dis 2003; 30:193-194.